Journal
/
/
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Journal JoVE
Médecine
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Médecine
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
DOI:

10:49 min

September 18, 2013

, , , ,

Chapitres

  • 00:05Titre
  • 01:39Phospho-protein Western Blot
  • 03:02Methylcellulose Assay
  • 04:24Evaluation of Phospho-protein Inhibition in vivo
  • 05:39Evaluation of Anti-leukemia Activity of TKIs in ALL Xenograft Models
  • 08:13Results: Biochemical and Functional Effects Mediated by TKIs
  • 10:07Conclusion

Summary

Traduction automatique

Receptor tyrosine kinases are ectopically expressed in many cancers and have been identified as therapeutic targets in acute leukemia. This manuscript describes an efficient strategy for pre-clinical evaluation of tyrosine kinase inhibitors for the treatment of acute leukemia.

Vidéos Connexes

Read Article